磷酸化原癌基因c-kit抗体

磷酸化原癌基因c-kit抗体Quantity size:

0.1ml

Concentration:

1mg/ml   Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

c-Kit is a transmembrane tyrosine kinase encoded by the cKit proto oncogene. c-Kit acts to regulate a variety of biological responses including cell proliferation, apoptosis, chemotaxis and adhesion.磷酸化原癌基因c-kit抗体 Ligand binding to the extracellular domain leads to autophosphorylation on several tyrosine residues within the cytoplasmic domain, and activation. Mutations in c-Kit have been found to be important for tumor growth and progression in a variety of cancers including mast cell diseases, gastrointestinal stromal tumor, acute myeloid leukemia, Ewing sarcoma and lung cancer. Phosphorylation at tyrosine 721 of c-Kit allows binding and activation of PI3 kinase.

磷酸化原癌基因c-kit抗体Also known as:

c-Kit (phospho Y936); c-Kit (phospho Tyr936); p-c-Kit (Tyr 936); C Kit; c-Kit; CD 117; CD117; CD117 antigen; KIT; KIT_HUMAN; Mast/stem cell growth factor receptor; Mast/stem cell growth factor receptor Kit; p145 c-kit; PBT; Piebald trait protein; Proto oncogene c Kit; Proto oncogene tyrosine protein kinase Kit; Proto-oncogene c-Kit; SCF Receptor; SCFR; soluble KIT variant 1; 磷酸化原癌基因c-kit抗体Stem cell factor receptor; tyrosine protein kinase Kit; Tyrosine-protein kinase Kit; v kit Hardy Zuckerman 4 feline sarcoma viral oncogene homolog; v kit Hardy Zuckerman 4 feline sarcoma viral oncogene like protein; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, .

●

磷酸化原癌基因c-kit抗体Immunogen: KLH conjugated Synthesised phosphopeptide derived from human c-kit around the phosphorylation site of Tyr936.

●

Predicted Molecular Weight: 107kDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl229Mu01白介素2受体β(IL2Rβ)多克隆抗体Polyclonal Antibody to Interleukin 2 Receptor Beta (IL2Rb)

kl229Ra01白介素2受体β(IL2Rβ)多克隆抗体Polyclonal Antibody to Interleukin 2 Receptor Beta (IL2Rb)

kl229Si01白介素2受体β(IL2Rβ)多克隆抗体Polyclonal Antibody to Interleukin 2 Receptor Beta (IL2Rb)

kl230Hu01丝氨酸蛋白酶1(PRSS1)多克隆抗体Polyclonal Antibody to Protease, Serine 1 (PRSS1)

kl230Ra01丝氨酸蛋白酶1(PRSS1)多克隆抗体Polyclonal Antibody to Protease, Serine 1 (PRSS1)

kl231Cp01尿皮质素1(UCN1)多克隆抗体Polyclonal Antibody to Urocortin 1 (UCN1)

kl231Hu01尿皮质素1(UCN1)多克隆抗体Polyclonal Antibody to Urocortin 1 (UCN1)

kl231Mu01尿皮质素1(UCN1)多克隆抗体Polyclonal Antibody to Urocortin 1 (UCN1)

kl231Ra01尿皮质素1(UCN1)多克隆抗体Polyclonal Antibody to Urocortin 1 (UCN1)

kl233Bo01蛋白激酶Cη(PKCη)多克隆抗体Polyclonal Antibody to Protein Kinase C Eta (PKCh)

kl233Hu01蛋白激酶Cη(PKCη)多克隆抗体Polyclonal Antibody to Protein Kinase C Eta (PKCh)

kl233Mu01蛋白激酶Cη(PKCη)多克隆抗体Polyclonal Antibody to Protein Kinase C Eta (PKCh)

kl233Ra01蛋白激酶Cη(PKCη)多克隆抗体Polyclonal Antibody to Protein Kinase C Eta (PKCh)

kl234Hu01免疫球蛋白G4(IgG4)多克隆抗体Polyclonal Antibody to Immunoglobulin G4 (IgG4)

kl235Hu01补体1抑制因子(C1INH)多克隆抗体Polyclonal Antibody to Complement 1 Inhibitor (C1INH)

kl235Mu01补体1抑制因子(C1INH)多克隆抗体Polyclonal Antibody to Complement 1 Inhibitor (C1INH)

kl235Ra01补体1抑制因子(C1INH)多克隆抗体Polyclonal Antibody to Complement 1 Inhibitor (C1INH)

kl235Rb51补体1抑制因子(C1INH)多克隆抗体Polyclonal Antibody to Complement 1 Inhibitor (C1INH)